A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis

NCT01122914 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

NIH

Sponsor class

Conditions

Anakinra
Kineret
Atopic Dermatitis
Eczema
Allergic Disease

Interventions

DRUG: Anakinra

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)